The lovely Carole and David from Wales speak out about why it is so important to have access to Abraxane.
Carole said: “We are delighted with the news that pancreatic cancer patients in Wales will be able to continue access to Abraxane.
“This treatment is the reason that my husband is still alive today and allowed us to spend precious time together, which we may not have had if he wasn’t able to access Abraxane.
“Pancreatic cancer is such a horrific and aggressive disease – it is such a relief for patients that this new treatment in almost 20 years isn’t going to be taken away from them.”
Like Carole, we are delighted that pancreatic cancer patients in Wales will be able to continue to access Abraxane. As many of you know this drug was removed from the Cancer Drugs Fund list in England last year, we will continue to fight for the reinstatement of Abraxane so patients in England can also benefit to this life-extending drug.
Pancreatic cancer drug to remain available on the Welsh NHS
A drug which provides hope to pancreatic cancer patients will continue to be made available on the Welsh NHS. The National Institute for Health and Care Excellence (NICE) decided not to recommend Abraxane for use within the NHS in England or Wales in October 2015.